- Home
- PRAA vs CSTL Comparison
PRAA vs CSTL Comparison
Compare PRAA & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAA
- CSTL
- Stock Information
- Founded
- PRAA 1996
- CSTL 2007
- Country
- PRAA United States
- CSTL United States
- Employees
- PRAA N/A
- CSTL 761
- Industry
- PRAA Finance: Consumer Services
- CSTL Medical Specialities
- Sector
- PRAA Finance
- CSTL Health Care
- Exchange
- PRAA Nasdaq
- CSTL Nasdaq
- Market Cap
- PRAA 790.6M
- CSTL 576.3M
- IPO Year
- PRAA N/A
- CSTL 2019
- Fundamental
- Price
- PRAA $19.89
- CSTL $20.21
- Analyst Decision
- PRAA Strong Buy
- CSTL Strong Buy
- Analyst Count
- PRAA 2
- CSTL 6
- Target Price
- PRAA $32.00
- CSTL $40.33
- AVG Volume (30 Days)
- PRAA 286.4K
- CSTL 453.1K
- Earning Date
- PRAA 05-05-2025
- CSTL 05-01-2025
- Dividend Yield
- PRAA N/A
- CSTL N/A
- EPS Growth
- PRAA N/A
- CSTL N/A
- EPS
- PRAA 1.79
- CSTL 0.62
- Revenue
- PRAA $1,114,524,000.00
- CSTL $332,069,000.00
- Revenue This Year
- PRAA $7.04
- CSTL N/A
- Revenue Next Year
- PRAA $7.29
- CSTL $10.07
- P/E Ratio
- PRAA $11.11
- CSTL $32.60
- Revenue Growth
- PRAA 38.87
- CSTL 51.09
- 52 Week Low
- PRAA $18.64
- CSTL $16.97
- 52 Week High
- PRAA $28.64
- CSTL $35.84
- Technical
- Relative Strength Index (RSI)
- PRAA 33.48
- CSTL 25.47
- Support Level
- PRAA $19.49
- CSTL $20.34
- Resistance Level
- PRAA $21.45
- CSTL $22.58
- Average True Range (ATR)
- PRAA 1.02
- CSTL 1.56
- MACD
- PRAA -0.35
- CSTL -0.57
- Stochastic Oscillator
- PRAA 13.38
- CSTL 7.89
About PRAA PRA Group Inc.
PRA Group Inc is a leader in acquiring and collecting nonperforming loans. The company returns capital to banks and other creditors to help expand financial services for consumers in the Americas, Europe, and Australia. It is also engaged in providing fee-based services on class action claims recoveries in the United States. The company's portfolio segments include; Core, which is engaged in purchasing and collecting nonperforming loans, which the originators have not chosen not to pursue, and the Insolvency segment which is engaged in purchasing and collecting nonperforming loans where the customer is involved in a bankruptcy proceeding.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME, among others. The company's test portfolio consists of test offerings to aid clinicians in the diagnosis and treatment of cancers or precancerous diagnoses in the fields of dermatology, gastroenterology, and ophthalmology and a pharmacogenomics ("PGx") test to guide optimal drug treatment for patients diagnosed with depression, anxiety, and other mental health conditions.